State approves $50,000 investment for Clarksville drug company
The Maryland Department of Business and Economic Development has approved a $50,000 investment for Neuronascent Inc., a small molecule drug development company in Clarksville.
The investment will be made through the department's Challenge Investment Fund, a program to assist small start-up companies in the high technology sector.
The investment will allow the company to continue work on a therapeutic drug for Alzheimer's disease, said Judith Kelleher-Andersson, the company's founder, president and chief scientific officer, according to a news release.
The company's work is focused on promoting neurogenesis and neuroprotection to reverse cognitive impairment in patients with Alzheimer's, stroke or depression.
Neuronascent has laboratories in Rockville and Walkersville.
Small-business fin ancier planning its fifth fundraiser for May 15
j-ref, a small-business financier in Howard County, will hold its fifth fundraiser, "j-ref's Bipartisan Bash," from 5 p.m. to 7:30 p.m. May 15 in the Rouse Company Foundation Student Services Hall at Howard Community College.
The event, which celebrates entrepreneurship, costs $50 a ticket. Sponsorship opportunities are available.
j-ref, which has its headquarters in the Center for Business and Technology Development in Columbia, is a private, not-for-profit funding source for Howard County startup and emerging companies. In addition to offering business loans up to $250,000, j-ref works with its partners to offer help with business advice, planning and education.
The organization maintains partnerships with Howard County government, the Howard County Economic Development Authority, Howard County Chamber of Commerce, Baltimore-Washington Corridor Chamber of Commerce, Howard Community College, and the business community.
Business Digest items may be sent to email@example.com or faxed to 410-715-2816.